Argentina Unveils $350,000 ‘Golden Passport’ Program Ahead of Q4 Launch
Argentina plans to open citizenship-by-investment applications in Q4 2026, with a $350,000 contribution, an $800,000 bond option and separate family costs.
This page serves as the chronological archive of all MarketSpeaker content, organizing published material by date rather than topic or format. It aggregates news, briefs, guides, and other editorial outputs into a time-based structure, allowing readers to track coverage across specific periods. Designed for researchers, analysts, and returning readers, the archive provides a clear historical view of market narratives and reporting cycles. Unlike category or tag pages, it emphasizes temporal navigation over thematic grouping.
Argentina plans to open citizenship-by-investment applications in Q4 2026, with a $350,000 contribution, an $800,000 bond option and separate family costs.
Nvidia reaches a new intraday record, taking its estimated market value above $5.72 trillion as investors assess AI earnings and a larger buyback program.
Banks’ AI expansion is changing financial careers, with specialist roles, higher pay estimates and internal training reshaping opportunities for workers.
September payrolls rose by only 29,000 as unemployment edged up to 4.2%, wage growth slowed and downward revisions weakened the summer hiring picture.
Gasoline models accounted for less than half of global new-vehicle sales in the first half of 2026, Nikkei reported, as higher oil prices sharpened the appeal of electric vehicles.
Eurozone inflation accelerated to 3.8% in September as energy prices surged, while core inflation edged up to 2.5% after the ECB’s latest rate increase.
The dollar held near a 17-month high against the euro as rising bond yields, French fiscal concerns and energy costs pressured Europe ahead of U.S. jobs data.
Nike plans job cuts from 2027 as Greater China sales fall 22%, deepening a restructuring aimed at reducing costs and rebuilding its marketplace.
Nike shares fell about 5% after its results, extending a slide to 13-year lows as a revenue miss and weak annual outlook overshadowed an earnings beat.
Accenture and Synopsys rally on financial updates, Vicor lifts its outlook, and a patent ruling sends United Therapeutics and Liquidia in opposite directions.